StockNews.AI
HUM
StockNews.AI
106 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Humana Inc. – HUM

1. Pomerantz LLP is investigating investor claims against Humana. 2. DOJ filed a lawsuit alleging illegal kickbacks in Medicare enrollments. 3. Humana's stock dropped 2.36% following the DOJ announcement. 4. The investigation looks into possible securities fraud by Humana's officers. 5. Class action joins focus on corporate misconduct within health insurance.

3m saved
Insight
Article

FAQ

Why Bearish?

DOJ's lawsuit could lead to financial penalties and further stock declines. Historical examples show similar lawsuits negatively impact stock prices of companies involved.

How important is it?

The legal investigation and allegations have significant implications for investor confidence. Market reactions indicate a clear concern regarding Humana's legal exposure.

Why Long Term?

Ongoing investigations or lawsuits can affect Humana's reputation and operations. Previous cases of legal issues often have prolonged effects on stock valuations.

Related Companies

UNHANTMCI
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Humana and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On May 1, 2025, the U.S. Department of Justice (“DOJ”) announced the filing of a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana, “alleg[ing] that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers’ Medicare Advantage plans.”  On news of the DOJ’s lawsuit, Humana’s stock price fell $6.20 per share, or 2.36%, to close at $256.04 per share on May 1, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News